Abstract
Asthma is the most common chronic health condition affecting children and a leading cause of emergency department visits and hospitalizations. The diagnosis of asthma can be challenging, but focusing on pertinent aspects of the clinical history can help establish the proper diagnosis. Asthma symptoms can be triggered by exposure to multiple different triggers, which may occur acutely or on a chronic basis. The level of asthma severity and/or control can be readily assessed for all patients and should be utilized to guide treatment. Asthma therapy relies upon the acquisition of self-management skills, use of controller medications for persistent asthma, and avoidance of known triggers. There are multiple types of medications that can be utilized to help control persistent asthma, with inhaled corticosteroids as the mainstay of treatment. Asthma varies considerably in regard to phenotypes, endotypes, severity, and prognosis. This chapter will help identify factors specific to each individual that contribute to the heterogeneity of asthma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akinbami LJ, Simon AE, Rossen LM. Changing trends in asthma prevalence among children. Pediatrics. 2016;137(1):e20152354.
Nath JB, Hsia RY. Children’s emergency department use for asthma, 2001–2010. Acad Pediatr. 2015;15(2):225–30.
Hasegawa K, Tsugawa Y, Brown DFM, Camargo CA. Childhood asthma hospitalizations in the United States, 2000-2009. J Pediatr. 2013;163(4):1127–33.e3.
Sullivan PW, Ghushchyan V, Navaratnam P, Friedman HS, Kavati A, Ortiz B, Lanier B. The national cost of asthma among school-aged children in the United States. Ann Allergy Asthma Immunol. 2017;119(3):246–52.
Arroyo AJC, Chee CP, Camargo CA Jr, Wang NE. Where do children die from asthma? National data from 2003 to 2015. J Allergy Clin Immunol Pract. 2017. Epub ahead of print in press
Burbank AJ, Sood AK, Kesic MJ, Peden DB, Hernandez ML. Environmental determinants of allergy and asthma in early life. J Allergy Clin Immunol. 2017;140(1):1–12.
Daley D. The evolution of the hygiene hypothesis: the role of early-life exposures to viruses and microbes and their relationship to asthma and allergic diseases. Curr Opin Allergy Clin Immunol. 2014;14(5):390–6.
Lynch SV, Boushey HA. The microbiome and development of allergic disease. Curr Opin Allergy Clin Immunol. 2016;16(2):165–71.
National Asthma Education and Prevention Program. Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol. 2007;120(5):S94–138.
Schatz M, Rosenwasser L. The allergic asthma phenotype. J Allergy Clin Immunol Pract. 2014;2(6):645–8.
Murdoch JR, Lloyd CM. Chronic inflammation and asthma. Mutat Res. 2010;690(1–2):24–39.
Spycher BD, Silverman M, Kuehni CE. Phenotypes of childhood asthma: are they real? Clin Exp Allergy. 2010;40(8):1130–41.
Lotvall J, Akdis CA, Bacharier LB, Bjermer L, Casale TB, Custovic A, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol. 2011;127(2):355–60.
Smith JA, Woodcock A. Chronic cough. N Engl J Med. 2016;375(16):1544–51.
Gautier C, Charpin D. Environmental triggers and avoidance in the management of asthma. J Asthma Allergy. 2017;10:47–56.
Boulet LP, Turmel J, Irwin RS, CHEST Expert Cough Panel. Cough in the athlete: CHEST guideline and expert panel report. Chest. 2017;151(2):441–54.
Hull JH, Ansley L, Price OJ, Dickinson JW, Bonini M. Eucapnic voluntary hyperpnea: gold standard for diagnosing exercise-induced bronchoconstriction in athletes? Sports Med. 2016;46:1083–93.
Porsbjerg C, Menzies-Gow A. Co-morbidities in severe asthma: clinical impact and management. Respirology. 2017;22(4):651–61.
Dundas I, Mckenzie S. Spirometry in the diagnosis of asthma in children. Curr Opin Pulm Med. 2006;12(1):28–33.
Tang S, Xie Y, Yuan C, Sun X, Cui Y. Fractional exhaled nitric oxide for the diagnosis of childhood asthma: a systematic review and meta-analysis. Clin Rev Allergy Immunol. 2016. Doi:https://doi.org/10.1007/s12016-016-8573-4
Nair P, Martin JG, Cockcroft DC, Dolovich M, Lemiere C, Boulet LP, et al. Airway hyperresponsiveness in asthma: measurement and clinical relevance. J Allergy Clin Immunol Pract. 2017;5(3):649–59.
Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, et al. Asthma control test: reliability, validity, and responsiveness in patients previously followed by asthma specialists. J Allergy Clin Immunol. 2006;117(3):549–56.
Skinner EA, Diette GB, Alqatt-Bergstrom PJ, Nguyen TT, Clark RD, Makson LE, et al. The asthma therapy assessment questionnaire (ATAQ) for children and adolescents. Dis Manag. 2005;7(14):305–13.
Juniper ER, Guffydd-Jones K, Ward S, Svensson K. Asthma control questionnaire in children: validation, measurement properties, interpretation. Eur Respir J. 2010;36:1410–6.
Bender BG. Nonadherence to asthma treatment: getting unstuck. J Allergy Clin Immunol Pract. 2016;4(5):849–51.
Nikander K, Nicholls C, Denyer J, Pritchard J. The evolution of spacers and valved holding chambers. J Aerosol Med Pulm Drug Deliv. 2014;27(Suppl 1):S4–23.
Cates CJ, Welsh EJ, Rowe BH. Holding chambers (spacers) versus nebulizers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev. 2013;9:CD000052.
Dinakar C, Oppenheimer J, Portnoy J, Bacharier LB, Li J, Kercsmar CM, et al. Management of acute loss of asthma control in the yellow zone: a practice parameter. Ann Allergy Asthma Immunol. 2014;113(2):143–59.
Wu AC, Carpenter JF, Himes BE. Mobile health applications for asthma. J Allergy Clin Immunol Pract. 2015;3(3):446–8.
Chipps BE. Inhaled corticosteroid therapy for patients with persistent asthma: learnings from studies of inhaled budesonide. Allergy Asthma Proc. 2009;30(3):217–28.
Loke YK, Blanco P, Thavarajah M, Wilson AM. Impact of inhaled corticosteroids on growth in children with asthma: systemic review and meta-analysis. PLoS One. 2015;10(7):e0133428.
Amlani S, McIvor RA. Montelukast in childhood asthma: what is the evidence for its use? Expert Rev Respir Med. 2011;5(1):17–25.
Chauhan BF, Chartrand C, Ni Chroinin M, Milan SJ, Ducharme FM. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children. Cochrane Database Syst Rev. 2015;11:CD007949.
Anderson WC 3rd, Szefler SJ. New and future strategies to improve asthma control in children. J Allergy Clin Immnol. 2015;136(4):848–59.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Stukus, D.R., Anderson, W.C. (2018). Asthma: A Heterogeneous and Challenging Chronic Condition. In: Stukus, D. (eds) Allergies and Adolescents. Springer, Cham. https://doi.org/10.1007/978-3-319-77485-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-77485-5_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-77484-8
Online ISBN: 978-3-319-77485-5
eBook Packages: MedicineMedicine (R0)